Canada’s three research funding agencies have launched the Tri-agency Interdisciplinary Peer Review Committee; Alberta creates a platform to boost clinical trials; Ontario Tech University is designated a collaboration centre by the UN International Atomic Energy Agency, and more.
This week in The Short Report, the Canadian Association of Science Centres receives funding to address vaccine misinformation while U of T targets strategies to reduce fear of needles; the University of Alberta receives industry funding to bolster wheat-breeding capacity, the Rideau Hall Foundation recognizes excellence in innovation, and more.
The 2021 federal budget gives a big boost to the NRC’s Industrial Research Assistance Program, BC budget provides $500 million to new fund for tech startups, US President Joe Biden proposes funding surge for federal research agencies, Canada’s Stem Cell Network to receive $45 million dollars for regenerative medicine therapies, and more.
The Government of Canada seeks to bolster Canada’s biomanufacturing capacity, D-Wave receives $40 million to accelerate Canada’s quantum technology development, the federal government invests in Canada’s longest-ever study on aging, Quebec’s Lion Electric gets ready to break ground on a new battery manufacturing plant, and more.
The Brookfield Institute and the Munk School of Global Affairs produce an online tool to monitor data and analysis of Canada’s inclusive innovation system; U of T and Denmark’s Novo Nordisk A/S invest $40 million on supporting healthier urban populations and finding solutions for chronic illnesses, and more.
The NGen supercluster has awarded $27 million in funding for 12 advanced manufacturing projects that can supply critical health care products to combat COVID-19. The funding includes $5 million for Providence Therapeutics and partner Northern RNA to establish manufacturing capacity in Calgary for Providence’s made-in-Canada vaccine.
Canada’s Top corporate R&D spenders reported a 7.5% increase in FY2019 R&D spending, down from 2018 but still described as “a very strong year”
The federal government needs to support an inclusive engineering biology ecosystem that leverages Canadian-grown capacities across industry, academia and government, Bettina Hamelin, president and CEO of Ontario Genomics, says in an editorial. Canada needs a comprehensive and aligned roadmap for a public-private partnership and investment strategy to benefit from the increasing opportunities in this emerging sector, she says.
Formed in 2019 from a union of the Centre for Drug Research and Development (CDRD) and the NEOMED Institute, adMare Bioinnovations has already launched 10 companies to date.
Vancouver-based biotech firm AbCellera, using its technology spun off research at University of British Columbia, is fast-tracking testing and clinical trials of therapeutic antibodies against COVID-19.